Sexually transmitted infections (STIs) are becoming more common, and doctors are seeing a growing number of people infected with multiple pathogens at the same time. A recent case in Vietnam involved a man under 30 who tested positive for six different sexually transmitted infections, including HSV-2, gonorrhea, Mycoplasma hominis, Ureaplasma urealyticum, Gardnerella vaginalis, and Candida.
According to specialists, co-infections are becoming increasingly frequent due to factors such as reduced condom use, multiple sexual partners, dating apps, and other high-risk sexual behaviors. Once one STI damages genital tissue, it becomes easier for additional bacteria, viruses, or fungi to enter the body.
Improved diagnostic tools, such as Multiplex PCR testing, are also helping doctors detect multiple infections that older methods often missed. However, many people still delay seeking medical care because of stigma, allowing infections to worsen and increasing the risk of transmission.
Experts emphasize that preventing STIs requires consistent condom use, limiting high-risk sexual behaviors, regular STI screening for sexually active individuals with multiple partners, prompt medical treatment, and ensuring that sexual partners are treated as well. Early diagnosis and treatment help reduce complications, prevent antibiotic resistance, and limit the spread of infections throughout the community.
📄 Article link in the comments. 👇
Cyllene Therapeutics raises $37M to advance HSV-1 gene therapy platform for neurogenic bladder
Cyllene Therapeutics has secured $37 million in Series C funding to advance EG110A, a gene therapy for severe neurogenic bladder disorders, into **Phase IIb/III clinical trials. The therapy uses a non-replicating HSV-1 (herpes simplex virus type 1) vector to deliver genes directly to bladder tissue.
Unlike HSV-based therapies aimed at treating herpes infections, this approach repurposes HSV-1 as a delivery vehicle because of its natural ability to target nerve cells. The virus has been engineered so it cannot replicate or cause herpes disease. EG110A is designed to selectively reduce overactive bladder nerve signaling while preserving normal bladder function, potentially providing a longer-lasting treatment than current options.
The new funding will also support expansion of Cyllene's HERMES platform, which is developing additional neurological gene therapies using the same HSV-1 vector technology. While this research is not a treatment or cure for HSV infection, it highlights how herpes virus biology is being harnessed for innovative medical applications.
https://t.co/HibmfZXjcY
@HerpesSupport_H Thank you so much for all that you do. Enlightening us on the herpes landscape. The Good, bad and neutral news. You’ve helped me realize that medicine is moving and helped me keep my sanity and faith
in science intact.
5/ It's important to remember that animal studies do not guarantee the same outcomes in humans. However, these results strengthen the preclinical safety profile of pritelivir and support its continued clinical development.
My childhood friend died from sickle cell disease. She took her last breath right in front of me when we were only 13 years old. Knowing that a cure is now changing lives fills my heart with joy. May future generations never have to endure what so many families have suffered.
🇳🇿 Big recognition for herpes awareness at Cannes Lions 2026.
Motion Sickness and the New Zealand Herpes Foundation have been shortlisted in the Creative Effectiveness Lions category for their campaign, "Make New Zealand the Best Place in the World to Have Herpes." The campaign continues to gain international acclaim for challenging stigma through bold, creative public education. 🦁
#HerpesAwareness #HSV #CannesLions #PublicHealth #CreativityForGood
https://t.co/5KPPbCs4Ip
🚀 Gene therapy is proving that diseases once thought incurable can be treated at their genetic roots. The recent functional cure of sickle cell disease is another reminder of what's possible when science advances.
For the HSV community, breakthroughs in gene editing and gene therapy offer real hope that a functional or even sterilizing cure may one day become reality. 💜
#HerpesCure #GeneTherapy #GeneEditing
A functioning public health system should also mean investing in diseases that affect billions. HSV infects most of the world's population, yet funding for better treatments and a cure remains far behind the need.
A neurologist highlights that herpes is often underestimated. While many infections are mild, HSV can sometimes lead to serious complications affecting the nervous system, eyes, newborns, and immunocompromised individuals. Early diagnosis and treatment remain important. #HerpesAwareness #HSV #PublicHealth
https://t.co/dpMGXGlWKp
Herpes isn't just physically uncomfortable—it’s a mental health crisis. The isolation and shame cause real, severe psychological distress, including suicidal ideation. We need to stop the jokes, change the conversation, and save lives. #cureHSV@HerpesSupport_H@HerpesAdvocate@herpesMiami@Men_Sex_Health